Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: Three-month follo
Salomon Undhof — Vintage and Vine
The cost and value of cancer drugs – are new innovations outpacing our ability to pay?
White Matter Changes in Patients with Breast Cancer Treated with High-Dose Chemotherapy and Autologous Bone Marrow Support
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
OncologyEducation on Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiEBcN https://t.co/BzobspfqNg" / Twitter